日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigating the Risk of Arrhythmogenesis Associated With Fentanyl Abuse Using Human and Mouse Cardiomyocytes

利用人类和小鼠心肌细胞研究芬太尼滥用相关的心律失常风险

Mondéjar-Parreño, Gema; Zhao, Shane Rui; Cao, Xu; Liu, Yu; Yang, Johnson Y; Jahng, James W S; Leitz, Jeremy; Wu, David; Sayed, Nazish; Jalife, José; Wu, Joseph C

Combinatory Treatment to Alleviate Cellular Stress and Improve Skeletal Muscle Phenotype in Spinal Muscular Atrophy

联合治疗缓解脊髓性肌萎缩症患者的细胞应激并改善其骨骼肌表型

Zeng, Wenshu; Kong, Xiaohui; Caudal, Arianne; Zhao, Shane Rui; Alamana, Christina; Melesio, Juan; Ren, Lu; Guzman, Jessica; Pang, Paul D; Howell, Kelly; Chen, Karen S; Day, John W; Wu, Joseph C

An FDA-approved drug structurally and phenotypically corrects the K210del mutation in genetic cardiomyopathy models.

FDA 批准的一种药物在结构和表型上纠正了遗传性心肌病模型中的 K210del 突变

Wang Ping, Ahmed Mahmoud Salama, Nguyen Ngoc Uyen Nhi, Menendez-Montes Ivan, Hsu Ching-Cheng, Farag Ayman B, Thet Suwannee, Lam Nicholas T, Wansapura Janaka P, Crossley Eric, Ma Ning, Zhao Shane Rui, Zhang Tiejun, Morimoto Sachio, Singh Rohit, Elhelaly Waleed, Tassin Tara C, Cardoso Alisson C, Williams Noelle S, Pointer Hayley L, Elliott David A, McNamara James W, Watt Kevin I, Porrello Enzo R, Sadayappan Sakthivel, Sadek Hesham A

CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity

利用 CRISPRi/a 对人类 iPSC-心肌细胞进行筛选,发现糖酵解激活是阿霉素诱导心脏毒性的一个可药物靶点。

Chun Liu ,Mengcheng Shen ,Yanxia Liu ,Amit Manhas ,Shane Rui Zhao ,Mao Zhang ,Nadjet Belbachir ,Lu Ren ,Joe Z Zhang ,Arianne Caudal ,Masataka Nishiga ,Dilip Thomas ,Angela Zhang ,Huaxiao Yang ,Yang Zhou ,Mohamed Ameen ,Nazish Sayed ,June-Wha Rhee ,Lei S Qi ,Joseph C Wu

Generation of induced pluripotent stem cell lines from South Asian ethnicity

南亚裔人群诱导性多能干细胞系的产生

Yaser Khokhar, Ava Bhowmik, Shane Rui Zhao, Zachary Cook, Shriram Nallamshetty, Joseph C Wu

Stepwise Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pericytes to Model Coronary Microvascular Dysfunction

利用人诱导多能干细胞逐步生成心脏周细胞以模拟冠状动脉微血管功能障碍

Shen, Mengcheng; Liu, Chun; Zhao, Shane Rui; Manhas, Amit; Sundaram, Laksshman; Ameen, Mohamed; Wu, Joseph C

SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant

SGLT2抑制剂可改善与常见的ALDH2酒精潮红变异相关的内皮功能障碍

Guo, Hongchao; Yu, Xuan; Liu, Yu; Paik, David T; Justesen, Johanne Marie; Chandy, Mark; Jahng, James W S; Zhang, Tiejun; Wu, Weijun; Rwere, Freeborn; Zhao, Shane Rui; Pokhrel, Suman; Shivnaraine, Rabindra V; Mukherjee, Souhrid; Simon, Daniel J; Manhas, Amit; Zhang, Angela; Chen, Che-Hong; Rivas, Manuel A; Gross, Eric R; Mochly-Rosen, Daria; Wu, Joseph C

Protocol to generate cardiac pericytes from human induced pluripotent stem cells

从人类诱导性多能干细胞生成心脏周细胞的方案

Mengcheng Shen, Shane Rui Zhao, Yaser Khokhar, Li Li, Yang Zhou, Chun Liu, Joseph C Wu

Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy

PDGFRA 信号的激活导致与细丝蛋白 C 相关的心律失常性心肌病

Suet Nee Chen, Chi Keung Lam, Ying-Wooi Wan, Shanshan Gao, Olfat A Malak, Shane Rui Zhao, Raffaella Lombardi, Amrut V Ambardekar, Michael R Bristow, Joseph Cleveland, Marta Gigli, Gianfranco Sinagra, Sharon Graw, Matthew R G Taylor, Joseph C Wu, Luisa Mestroni

Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses

利用iPSC技术解析人类心脏细胞:细胞类型、实验方案和用途

Yu, Brian; Zhao, Shane Rui; Yan, Christopher D; Zhang, Mao; Wu, Joseph C